Lung infl ation and slicing
A solution of 1% low-melting-point agarose was prepared in HBSS by heating in a microwave oven. It was then cooled to 42°C and kept at that temperature until infl ation. Following euthanasia of the mice by CO 2 asphyxiation, lungs were defl ated by puncture of the diaphragm and the front rib cage was removed. The trachea was cannulated using a catheter (18G Safelet Cath; Exelint International, Los Angeles, CA) and lungs were infl ated with mOCT or agarose at 20 cm water pressure. The left lung was excised from the mouse, rinsed with HBSS, blotted dry, placed in a disposable cryomold embedded with OCT or mOCT, and then placed in a Ϫ 20°C freezer. The embedded lung was mounted onto a cutting chock with OCT and sliced at a thickness of 12 m with a cryostat (ReichertJung Cryocut 1800) at Ϫ 20°C. The lung sections were placed onto glass coverslips and stored for no longer than 1 week at Ϫ 20°C until matrix application and MALDI imaging. Additionally, another agarose-infl ated left lobe was formalin-fi xed and paraffi n-embedded (FFPE) using standard procedures. The FFPE left lobe was sliced at a thickness of 4 m with a microtome and placed onto glass coverslips. The coverslips were dipped into xylene twice to remove the paraffi n before matrix application. Two slices of an FFPE lung from one mouse, 5 slices of an OCT-embedded lung from one mouse, and at least 15 different slices of an mOCT-infl ated and -embedded lung from three different mice were analyzed by MALDI IMS. For the immunofl uorescence experiments described below, adjacent sections were collected onto Superfrost slides.
Matrix application
The glass coverslips containing the lung sections were attached to a stainless steel MALDI plate using copper tape, and the DHB matrix was deposited by sublimation ( 19 ) . The MALDI plate was attached to the condenser using doublesided thermally conductive tape (3M; St. Paul, MN). The conditions during sublimation of the DHB matrix were a pressure of 0.05 Torr, condenser temperature of 15°C (42 V applied to a heating mantle), and 275 mg DHB in the sublimator. The heat was applied for 11 min, which resulted in the deposition of a thin layer of DHB matrix. For negative-ion MALDI, imaging DHAP was used as the matrix and the conditions of sublimation were a pressure of 0.05 Torr, condenser temperature of 13°C (36 V applied to a heating mantle), and 150 mg DHAP in the sublimator. The heat was applied for 13 min, which resulted in the deposition of a thin layer of DHAP matrix. After MALDI imaging was completed, the glass coverslip containing the lung section was carefully removed from the MALDI plate and dipped in methanol to remove the matrix and fi x the tissue prior to modifi ed Giemsa staining, which was performed using standard protocols.
for a particular lipid molecular species of interest are not readily available. Neither of these methods provides spatial distribution information for specifi c lipid molecular species in a tissue, and consequently, there is a need for an effective method that indicates the localization and acyl chain composition of lipids in tissue. Localization of lipid molecular species in some tissues has been examined by microdissection of specifi c anatomical features followed by solvent extraction and LC/MS or LC/MS/MS analysis ( 14 ) ; however, the nonrigid nature of the lung, with interlaced architecture of airways and blood vessels of varying size and shape, makes this organ poorly suited for this approach.
MALDI imaging MS (IMS) has been developed as a powerful method for investigating the distribution of biomolecules within tissues ( 15 ) . Analyte ions are produced directly from a tissue slice coated with MALDI matrix, and sequential mass spectra are acquired by rastering the laser beam across the tissue surface. This method is unique, compared with other imaging methods, because the distribution as well as the composition of many compounds of interest can be determined in a single experiment. Images can be obtained by plotting the intensity of the analytes of interest as a function of the x-y coordinates. Although much research in MALDI IMS has focused on the spatial distribution of proteins and peptides ( 15 ) , the majority of ion current generated by MALDI IMS is related to desorption of phospholipids from the tissue ( 16 ) . Recent studies have also revealed that the abundance of the phosphatidylcholine (PC)-related ions in MALDI IMS images is remarkably correlated with local concentrations of that PC lipid in tissue regions ( 17 ) . Thus, MALDI IMS offers unique information about the molecular species present on a tissue without the need for specifi c probes or staining.
In order to preserve the normal lung architecture, most histological preparation methods require both infl ation and embedding of the lung ( 18 ) . In this study, it was determined that the traditional methods of lung histological preparations, agarose infl ation with either formalin fi xation paraffi n embedding or OCT embedding, were incompatible with MALDI IMS of phospholipids, and, therefore, a new infl ation and embedding agent was developed that was MALDI IMS compatible. Using MALDI IMS, phospholipid molecular species that contained either esterifi ed arachidonic acid or docosahexaenoic acid were localized to specifi c anatomical regions of the lung.
MATERIALS AND METHODS

Reagents
Low-melting-point agarose was obtained from Promega (Madison, WI). Polyvinyl alcohol (PVA) 6-98, 2,5-dihydroxybenzoic acid (DHB), 2,6-dihydroxyacetophenone (DHAP), and sodium azide were purchased from Sigma Aldrich Chemical Co. observed between m/z 700-850. This population of PC molecular species was used to evaluate the initial attempts to image phospholipids in the mouse lung. Lung samples obtained for histological studies typically are infl ated using low-melting agarose and either fi xed with formalin and embedded in paraffi n or embedded with OCT and frozen. The total positive ions obtained as a result of MALDI imaging of a FFPE lung resulted in the absence of phospholipid ion signal ( Fig. 1B ) . For example, ions at m/z 734.6 or 810.6, present as abundant [M+H] + in the lung homogenate ( Fig. 1A ) , were not abundant ions generated during
MALDI IMS
A quadrupole time-of-fl ight tandem mass spectrometer with an orthogonal MALDI source (QSTAR XL; Applied Biosystems/ MDS Sciex, Thornhill, Ontario, Canada) was used to acquire images. MALDI mass spectra were obtained using a nitrogen laser (337 nm) at a power of 100 J and a pulse rate of 20 Hz with an accumulation time of 243 ms per image spot. The MALDI plate was moved at a rate of 12.75 mm/min, and after each horizontal line was completed, the plate was moved vertically 50 m. The mass spectrometric data were processed using a specialized script for Analyst software (Applied Biosystems/MDS Sciex) at a mass resolution of 0.1 amu, and images were visualized using TissueView software (Applied Biosystems/MDS Sciex). The lateral resolution of this MALDI IMS technique is approximately 50 m. Collisional activation of selected ions was carried out using a relative collision energy of 40 V, with argon as collision gas.
Lung homogenization, lipid extraction, and ESI-MS
The mouse left lung was homogenized in 1:1 methanol/HBSS (1 ml) and the phospholipids were then extracted according to the method of Bligh and Dyer ( 20 ) . The extracted phospholipids from lung homogenate were resuspended in 60:20:20 (v/v/v) methanol-acetonitrile-water with 1 mM ammonium acetate for positive-and negative-ion MS analysis. Additionally, the PC lipids were separated by normal-phase HPLC from the other phospholipid classes ( 21 ) and resuspended in 60:20:20 (v/v/v) methanol-acetonitrile-water and infused into a Sciex API QTRAP mass spectrometer (PE Sciex; Toronto, Canada) at a fl ow rate of 5 l/min. In the negative-ion mode, the experimental parameters used to obtain the product ion spectra were an electrospray voltage of Ϫ 4,500 V, a declustering potential of Ϫ 50 V, and a collision energy of Ϫ 50 V.
Immunofl uorescence
Sections adjacent to those analyzed by MALDI were used for dual immunofl uorescence staining to aid in differentiation of airways from blood vessels in lung slices. Sections were placed at room temperature overnight, fi xed in 10% neutral buffered formalin for 1 h at room temperature, and washed in deionized water. Antigens were retrieved by the microwave method (15 min, 1,200 W) in 0.01 mM citrate buffer (pH 6.0). Slides were cooled to room temperature, washed with deionized water, and equilibrated in PBS for 5 min. Sections were blocked in blocking buffer (5% FBS in PBS) for at least 1 h. Primary and secondary antibodies were diluted in blocking buffer. Antigens were detected with mouse IgG2b anti-acetylated tubulin (Sigma; 1:8,000) and goat IgG anti-thrombomodulin (CD141; R and D Systems, 1:300), overnight at 4°C. Sections were washed with deionized water and equilibrated in 1× PBS for 10 min. Antigen-antibody complexes were detected with 1:500 (in blocking buffer) dilutions of secondary antibodies: Alexa 488-conjugated donkey anti-mouse IgG2b and Alexa 594-conjugated donkey anti-goat IgG (Invitrogen). Slides were counterstained with 1 µg/ml 4',6-diamidino-2-phenylindole (DAPI). Images were acquired using a Zeiss Imager. Z1 fl uorescent microscope (Zeiss) equipped with an Axiocam HRc black and white digital camera.
RESULTS
Infl ation and embedding of lungs
The positive-ion ESI MS of lipids solvent extracted from a mouse lung homogenate ( In sharp contrast, the MALDI images of m/z 782.6 ( Fig.  2C ) and m/z 806.6 ( Fig. 2D ) indicated that these phospholipid molecular ions were highly abundant along the edge of the putative airways observed in the modifi ed Giemsa stain ( . IVC ) . Additionally, the positive-ion CID spectra of m/z 782.6, 806.6, and 810.6 indicated that these ions were derived from a mixture of molecular species, owing to the appearance of an ion corresponding to a loss of trimethylamine and a sodiated cyclic 1,2-phosphodiester ion ( 26 ) and were probably composed of the sodium adduct of POPC, oleoyl-linoleoyl-PC, and stearoyloleoyl-PC, respectively. However, due to the low abundance of these characteristic sodiated PC ions in the positive-ion CID spectra, it was determined that these sodiated adducts were not the major PC species making up the ion abundance at each mass-to-charge ratio. In addition to airways, blood vessels are also abundant anatomical features in lung tissue. This was readily observed in the modifi ed Giemsa stain ( Fig. 2F ) , in which most of the blood vessels were still fi lled with blood, since no perfusion was performed and the tissue was not rinsed. Many of the phospholipids observed in the positive-ion MALDI images of the lung did not highlight the blood vessels ( Fig. 2A-D ) . However, the MALDI image of the ion at m/z 725.6 indicated the enrichment of this molecular Fig. IA-C ) . The next attempt at MALDI imaging of lung phospholipids was with an agarose-infl ated, OCT-embedded lung. The positive-ion MALDI mass spectrum of this preparation ( Fig. 1C ) indicated the presence of some phospholipids with low signal intensity, including a few of the major ions, such as m/z 734.6, present in the ESI mass spectrum of lung homogenate ( Fig. 1A ) . The MALDI images obtained of phospholipids in the agarose-infl ated, OCT-embedded lung were unimpressive, although some defi nition of the larger airways was observed (see supplementary Fig. ID-F ) .
OCT contains a benzalkonium salt as a preservative, which can suppress the ionization of analytes during the MALDI process ( 22 ) , and adducts of benzalkonium with endogenous PC lipids have also been observed as ions in MALDI mass spectra (data not shown). Therefore, a new embedding agent was developed that supported the lung tissue while it was cut on a cryostat and caused minimal interference in the MALDI mass spectrum in the phospholipid mass region ( m/z 700-900). The fi nal mOCT composition was 10% PVA 6-98 and 8% PPG 2000, which was based on the OCT composition and a previous study on the formulation of cryoembedding media ( 23 ) . The positive-ion MALDI mass spectrum of an mOCT-infl ated and -embedded lung directly from the tissue ( Fig. 1D ) indicated the presence of numerous phospholipid molecular species, such as m/z 706.6, 734.6, 760.6, 782.6, and 810.6, which were also present in the positive-ion ESI mass spectrum of lung homogenate ( Fig. 1A ) . Additionally, the MALDI mass spectrum of a lung slice ( Fig. 1D ) revealed an abundant ion at m/z 756.6 not present in the ESI mass spectrum of the extracted lung lipids. It is most likely that this ion corresponded to a sodiated PC species of m/z 734.6 by the addition of 22 daltons to the [M+H] + species. Although the ESI mass spectrum of lung homogenate ( Fig. 1A ) was obtained by controlling the ionic composition of the electrospray solvent, the MALDI ions would be subject to local concentrations of alkali metal ions in the tissue that can generate abundant Na + in the MALDI plume and adduct of this desorbed PC. In addition, the pulmonary morphology of the lung slices was preserved using mOCT when the stained slices were examined microscopically (see below). In general, the quality of the MALDI images obtained using mOCT were superior when compared with the MALDI images from FFPE and OCT-embedded lungs.
Positive-ion MALDI images
From the mass spectra obtained from each pixel across the lung tissue, an ion of interest can be extracted and an image of that particular ion distribution in the tissue can be visualized. The extracted-ion MALDI image of the mostabundant MALDI ion, m/z 734.6 ( Fig. 2A ) ( Fig. 3C ) , were magnifi ed at the boxed-in region of the lung tissue shown in Fig. 2F . From these two separate positive-ion MALDI images ( Fig.  3B, C ) , it appeared that PAPC and SM(d18:1/16:0)+Na were not colocalized, and when the positive-ion MALDI images were merged ( Fig. 3D ) , there was a clear difference in the localization of PAPC (green) and SM(d18:1/16:0)+Na (red).
The adjacent lung section was stained to visualize acetylated tubulin (green), specifi c for airway ciliated cells, and thrombomodulin (red), specifi c for blood vessels. In addition, DAPI was used to visualize cell nuclei. The DAPI counterstain of this lung section illustrated the lacy appearance of species at the edges of the pulmonary blood vessels ( Fig.  2E ) . The positive-ion CID spectrum for this ion directly from the tissue on the MALDI plate (see supplementary 
Immunohistochemistry
The blood vessels and airways in the lung were unequivocally identifi ed by dual immunofl uorescence on a lung section adjacent to that used for the MALDI imaging experiment. The modifi ed Giemsa stain ( Fig. 3A ) , along with the MALDI ion images of PAPC, m/z 782.6 ( Fig. 3B ) , and these combined data, it was concluded that both small and major airways had PUFA-containing phospholipids and that both small and large blood vessels contained SM(d18:1/16:0)+Na.
Negative-ion MALDI images
The phospholipid molecular species observed as abundant [M-H] Ϫ in the negative-ion ESI mass spectrum of solvent-extracted lipids from the lung homogenate ( Fig. 4A ) were quite similar to the molecular species present in the the alveolar region, as well as the characteristic nuclear shape and density of blood vessel and major airway cells ( Fig. 3E ). Higher magnifi cations of the immunofl uorescence images aided in the identifi cation of two major airways and one large blood vessel ( Fig. 3F-H ) . Additionally, capillaries present in the alveolar region were visualized with the thrombomodulin stain. MALDI IMS and immuno fl uorescence staining were also performed on adjacent lung sections that contained a main axial airway and a small blood vessel (see supplementary Fig. V ) . From were also present in the parenchyma, although with a much lower signal intensity. Similar MALDI images were observed in negative-ion mode for m/z 722.6, 1-O -hexadecenylarachidonoyl-PE (HAPE) (see supplementary Fig. VIIC ) and m/z 857.6, palmitoyl-arachidonoyl-PI (see supple mentary Fig. VIID) . These negative-ion MALDI images of arachidonate-containing phospholipids in the lung were similar to those of the PUFA-containing PC lipids, with a signal highly enriched at the edges of the airways.
DISCUSSION
Most tissues that have been examined by MALDI IMS are nonporous and do not require infl ation of the tissue or support by an embedding compound in order to obtain high-quality slices on the cryostat ( 27 ) . One of the challenges in preparing lung tissue for MALDI IMS is the spongy nature of this organ. Frozen, noninfl ated lung tissue was very diffi cult to section on the cryostat, and the resulting sections had compromised morphology (e.g., compressed alveoli); it became clear that infl ation of the lung was necessary in order to maintain the lung architecture. However, the two most-common lung preparation methods used for pulmonary histological studies, agarose infl ation with FFPE or OCT embedding, did not provide useful MALDI images (see supplementary Fig. I ). It is thought that the lack of phospholipid signal from an FFPE lung ( Fig. 1B ) is probably due to the ethanol dehydration step of the FFPE procedure, which would cause the phospholipids to be rinsed away. Additionally, the poor quality of the positive-ion MALDI image of the agarose-infl ated, OCT-embedded lung (see supplementary Fig. ID-F ) was in part due to the presence of OCT, which has been shown to alter the ions observed in mass spectra ( 22 ) , largely because the benzalkonium ion present as a preservative readily forms adduct ions with phospholipids and otherwise suppresses ion formation of species of interest. In order to achieve high-quality MALDI images of phospholipids in lung, it was necessary to develop new infl ation and cryoembedding media. The use of the modifi ed OCT cryoembedding agent, composed of 10% PVA 6-98 and 8% PPG 2000, resulted in MALDI mass spectra of phospholipids directly from the lung tissue ( Figs. 1D and 4B ) that were quite comparable to the ESI mass spectrum of homogenized lung ( Figs. 1A and 4A ) . The mOCT was essential for obtaining MALDI images that readily indicated the distribution of specifi c phospholipids in the lung ( Figs. 2, 5 ) .
Lung surfactant, made by type II alveolar cells, is a complex mixture composed primarily of phospholipids (80-90%), with PG and PC lipids accounting for 10% and 85%, respectively, of the total phospholipids in pulmonary surfactant ( 28 ) . The majority of PC in the pulmonary surfactant is present as DPPC (58%), PPoPC (13%), POPC (7.2%), and PMPC (4.7%) ( 29 ) . Additionally, the PG lipids found in surfactant of most mammals are present as palmitoyl-palmitoleoyl-PG, POPG, and PLPG ( 30, 31 ) . The MALDI images of these PG and PC surfactant lipids listed above ( Figs. 2A, B , and 5A; see supplementary Figs. IVA, B, and VIIA) indicated a relatively uniform intensity of these negative-ion MALDI mass spectrum of the entire left lung directly from the lung tissue ( Fig. 4B ) . The identity of the phospholipids that generated these negative ions was deduced from collisional activation of each abundant [M-H] Ϫ ion in the ESI data ( Fig. 4A ) , as well as the same ion observed in the MALDI IMS ( Fig. 4B ) . For example, the negative-ion MALDI CID spectra obtained directly from the tissue (see supplementary Fig. VIA, B) were consistent with the identifi cation of m/z 747.6 as palmitoyl-oleoyl-PG (POPG) and m/z 788.6 as stearoyl-oleoyl-PS (SOPS). The negative-ion MALDI CID spectra obtained directly from the tissue (see supplementary Fig. VIC, D) were consistent with the identifi cation of m/z 766.6 as stearoyl-arachidonoyl-PE (SAPE) and m/z 885.6 as stearoyl-arachidonoyl-PI (SAPI).
The negative-ion MALDI images reveal a unique distribution of phosphatidylglycerol (PG), phosphatidylserine, phosphatidylethanolamine (PE), and phosphatidylinositol (PI) lipid molecular species across the lung slice ( Fig. 5 ) . The MALDI images of m/z 747.6 and 788.6 ( Fig. 5A, B ) indicated that these molecular species are present in the lung parenchyma ( Fig. 5E ) . Additionally, the negative-ion MALDI images of m/z 745.6, palmitoyl-linoleoyl-PG (PLPG) (see supple mentary Additionally, the MALDI images of m/z 766.6 and 885.6 ( Fig. 5C, D ) indicated that these phospholipids were particularly abundant at the edges of the airways observed in the modifi ed Giemsa stain ( Fig. 5E ). These molecular species species are very intense at the edges of many airways. These PUFA-containing PC, PE, and PI lipids have been reported to be in very low abundance in pulmonary surfactant ( 31 ) , and it is reasonable to conclude that the observed signal for PUFA-containing PC, PE, and PI lipids originated from pulmonary cellular membranes. From the unique location of the highest concentration of these phospholipids, it would appear that the epithelial lining of airways would be the molecular species in the lung parenchyma. The distribution of the surfactant phospholipids in the MALDI images is quite characteristic of surfactant because of its prolifi c presence in the alveolar region, which is where the surfactant is synthesized, stored, and secreted.
The MALDI images of PUFA-containing PC, PE, and PI lipids ( Figs. 2C, D, most likely cellular origin; however, the spatial resolution of MALDI IMS ( ‫ف‬ 50 m) was not adequate to ascertain the exact cellular source of the PUFA-containing PC, PE, and PI lipid signals in the MALDI images of lung tissue. The phospholipid composition of the many pulmonary cell types has not been extensively studied, but limited studies on the phospholipid content of tracheal epithelial cells ( 32 ) and human fetal type II alveolar epithelial cells ( 33 ) have indicated that the PUFA-containing PC, PE, and PI lipids observed in the MALDI images are present in these cells.
The discovery that arachidonic acid-containing lipids are localized at highest concentrations in specifi c regions of the lung is valuable, because these lipids are the precursors to leukotriene and prostaglandin production. Incorporation of arachidonic acid into phospholipids occurs through the Lands cycle ( 34 ) and is probably mediated by the lysophospholipid acyl transferases MBOAT5 and MBOAT7 ( 35 ) . It is possible that the arachidonatecontaining PI, PC, and PE observed at the edges of the airways by MALDI IMS could be a source of the arachidonic acid that is the substrate for 5-lipoxygenase or cyclooxygenases and the eventual production of lipid mediators that affect airway conductance relevant to both asthma ( 36 ) and chronic obstructive pulmonary disease ( 37 ) . In a similar fashion, docosahexaenoate-containing phospholipids at this unique site might provide the precursor pool of the pro-resolution mediators from subsequent metabolism of this fatty acid ( 7 ) .
For the fi rst time, it was found that PUFA-containing phospholipids are present at high concentrations in the airways of pulmonary tissue in the mouse. Little is known about how such unique distributions of arachidonate-and docosahexaenoate-containing phospholipids change during alteration of biochemistry within the lung during lung disease or after exposure to environmental toxicants, but the MALDI IMS approach presented here makes it possible to investigate these questions.
